BioCryst Pharmaceuticals | BCRX - Despesa De Juros Sobre A Dívida





Despesa De Juros Sobre A Dívida Alterar Data
Alnylam Pharmaceuticals USD 82.05M 12.76M 2026-06
BioCryst Pharmaceuticals USD 21.71M 7.58M 2026-06
Chugai Pharma JPY 95M 260M 2025-12
Daiichi Sankyo JPY 3.57B 1.4B 2026-03
DBV Technologies USD 461K 323.71K 2025-03
Enanta Pharmaceuticals USD 1.96M 620K 2024-12
Gilead Sciences USD 247M 7M 2026-06
GlaxoSmithKline GBP 121M 46M 2026-06
Glaxosmithkline GBP 192.73M 14.79M 2026-03
Incyte USD 582K 13K 2026-06
Ionis Pharmaceuticals USD 18M 1000K 2026-06
Karyopharm Therapeutics USD 12.55M 66K 2026-03
Neurocrine Biosciences USD 1.1M 0 2024-03
Novavax USD 5.82M 342K 2025-12
PTC Therapeutics USD 3.25B 381.37M 2026-06
Regeneron Pharmaceuticals USD 11M 1.9M 2026-06
Roche Holding CHF 304M 7.5M 2025-06
Sarepta Therapeutics USD 21.51M 205K 2026-06
Ultragenyx Pharmaceutical USD 22M 1000K 2026-06
Vertex Pharmaceuticals USD 3.3M 0 2025-12